High switching and price sensitivity With affordability a primary barrier in the OOP market, patients may move fluidly between brands, generics, and suppliers in pursuit of the best value or simply availability
WL, LX, and HW wrote the manuscript
Results from such research do not constitute evidence that ColonBroom GLP-1 Booster as a finished product will produce particular outcomes in individuals
Put the 9-Phase Framework to work for your market Whether you need a one-off market sizing or an always-on intelligence partnership, our analysts can scope the right engagement in a 30-minute call
Bile acids are cholesterol metabolites produced in the liver (primary BAs) that can be transported to the intestines and modified by the gut microbiota (secondary BAs)
When in doubt, call our office